DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Dougados M, Béhier JM, Jolchine I et al.
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
Arthritis Rheum 2001;
44: 180-185
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.